Why ASX healthcare shares are a no-brainer for the 2020s

Here's why I think ASX healthcare shares like CSL Limited (ASX: CSL) are a no-brainer for 2020 investments.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I would describe ASX healthcare shares as a somewhat 'under-the-radar' sector of the share market. Sure, market-darling CSL Limited (ASX: CSL) has managed to sneak up to be one of the most popular ASX shares to hold in a modern portfolio.

But out of the ASX 50 (that's the largest 50 Aussie public companies) – only 4 are classified as belonging to the healthcare industry.

They are CSL, Ramsay Health Care Limited (ASX: RHC), Sonic Healthcare Limited (ASX: SHL) and Cochlear Limited (ASX: COH).

If you were splitting hairs, you could also throw in Medibank Private Ltd (ASX: MPL), although it's technically a Financial.

But I think healthcare is one of the best places to be investing as we begin the new decade. In my view, the under-representation of healthcare in the ASX 50 just means there's plenty of room for growth!

Why?

Well, I have 2 rock-solid (in my opinion, anyway) reasons.

1. Ageing demographics

It's no secret that our population is ageing. According to reporting in the Sydney Morning Herald, it's estimated that by the year 2056, there is expected to be just 2 workers for every 1 retiree – down from today's ratio of 4-to-1.

That's a scary statistic, but it's also one that I think indicates a lot of potential in the healthcare sector for investing today.

2. Government support

As our population ages, there is going to inevitably be more pressure on government services to provide the same level of care from fewer taxes being proportionally paid by less workers. As a result, I expect governments to increasingly rely on the private sector to fill this gap.

This might come through the use of higher tax incentives like the private health insurance rebate and Medicare levy, or grants to private health providers to shoulder some of this burden.

Whichever way the cookie crumbles, I think this sector will stand to benefit as we stare down this barrel.

Yes, I think the government will be buying more vaccines from CSL as time goes on.

Yes, I think Ramsay Health Care (and its extensive network of private hospitals) will benefit in more than one way from government policy in the future.

And yes, I think Medibank and other private insurers will continue to be encouraged by the state to take some of the pressure off Medicare.

Foolish takeaway

All in all, healthcare is a sector that I believe is a no-brainer to be investing in this decade and beyond, for the reasons outlined above. By looking at the demographic trends that are hitting our population, it's really not too hard to imagine the benefits that are going to flow into the healthcare sector as a whole. It's a pie I certainly want a slice of!

Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd., Ramsay Health Care Limited, and Sonic Healthcare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL share price leaping higher amid $1.9 billion funding news

ASX 200 investors are bidding up the CSL share price on Wednesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

Guess which ASX 200 healthcare share is jumping 7% on a guidance update

This healthcare share is performing better than expected in FY 2024.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

1 ASX healthcare stock that looks severely undervalued

I think this stock looks too cheap to miss.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Own Medibank shares? Here's why it's a rewarding day for you

Shareholders are getting a healthy boost today.

Read more »

Health professional looking at a laptop.
Healthcare Shares

Are CSL shares a must-buy in March?

Let's see what analysts are saying about this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

This ASX healthcare stock is up 72% on FDA news and 'historic moment'

Huge gains are been recorded by this stock on Tuesday. But why?

Read more »